Setting the Record Straight on #RepublicansCutMedicare

The messaging is effective politics. It is not accurate reporting.

Here is what actually happened, based on the Congressional Budget Office, Congressional Research Service, CMS announcements, and the legislative record.

The $536 Billion Number Was Real — and Then It Wasn’t

In July 2025, Congress passed and President Trump signed the One Big Beautiful Bill Act (OBBBA, Public Law 119-21). The bill extended and made permanent large portions of the 2017 tax cuts and included other fiscal changes. The Congressional Budget Office estimated it would increase deficits by roughly $3.4 trillion over a decade relative to the prior baseline.

Under the Statutory Pay-As-You-Go (PAYGO) Act of 2010, deficit-increasing legislation can trigger automatic across-the-board cuts (sequestration) to certain mandatory spending. Medicare provider payments are subject to these cuts, though limited to 4 percent per year. CBO scored the resulting Medicare payment reductions at approximately $45 billion in fiscal year 2026 and about $536 billion over the following years.

That sequester never took effect. In November 2025, Congress passed—and President Trump signed—H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 (Public Law 119-37). Section 8001 of that bill directed the Office of Management and Budget to clear the PAYGO scorecards, eliminating the potential sequester cuts, including those to Medicare.

This is not unusual. Congress has routinely waived these automatic cuts for years under both parties. The large automatic reduction cited in the hashtag was averted by the same Republican-controlled government that passed the underlying bill.

What the Bill Actually Did to Medicare

According to Congressional Research Service and CBO analyses of the enacted law, OBBBA’s direct Medicare provisions produced a net increase of about $8.6 billion in Medicare outlays over ten years. The major spending reductions in the package hit Medicaid, not Medicare.

The Medicare-related changes included:

• A temporary one-year increase in the Medicare Physician Fee Schedule conversion factor for 2026. When that temporary boost expires, 2027 rates fall relative to 2026 under existing law.

• Restrictions on new Medicare enrollment for certain categories of lawfully present non-citizens.

• Multi-year delays of Biden-era rules that would have streamlined enrollment in Medicare Savings Programs (which help low-income beneficiaries with premiums and cost-sharing) and certain nursing home staffing requirements.

• Adjustments to which orphan drugs are subject to the Inflation Reduction Act’s price negotiation process and some changes to pharmacy benefit manager rules under Part D.

These are policy choices with consequences. Restricting eligibility for non-citizens and delaying expansions of low-income assistance are real. Temporary payment patches that expire create rate pressure on physicians. None of them constitute an across-the-board cut to the benefits that American seniors who paid into the system receive.

Part D Premiums and Physician Payments

Two other items frequently wrapped into the hashtag deserve clarity.

Part D Premium Stabilization Demonstration: This was a temporary program created under the Biden administration to cushion premium spikes for standalone prescription drug plans after the Inflation Reduction Act redesigned Part D. CMS under the Trump administration announced on July 28, 2026, that it would end the demonstration after 2026, returning the program to ordinary market conditions. CMS Administrator Mehmet Oz has stated that most beneficiaries will see premium changes of less than $10 or even decreases, and that low-cost plans remain available. Critics project larger increases for a meaningful share of enrollees. Ending a temporary subsidy to insurers is not the same as cutting the statutory Part D benefit.

2027 Physician Fee Schedule: CMS’s proposed rule, released July 14, 2026, shows conversion factor decreases of roughly 1.2–1.7 percent (depending on alternative payment model participation). The primary driver is the expiration of the one-year 2.5 percent boost provided by Public Law 119-21 for calendar year 2026. Additional methodology changes (practice expense updates and same-day evaluation-and-management adjustments) are projected to hit certain specialties, including dermatology, harder than others. These are reductions in what Medicare pays providers. Lower provider rates can affect access over time if physicians limit new Medicare patients—a complaint that has existed for decades under both parties. They are not reductions in the benefits or covered services seniors receive.

Separately, CMS has imposed temporary freezes on new enrollments by home health and hospice agencies as part of a fraud crackdown. Existing providers continue operating. Targeting suspected waste is not a benefit cut.

The Broader Pattern

Much of the online rhetoric simply conflates Medicare and Medicaid. The large coverage losses projected from OBBBA come overwhelmingly from Medicaid changes (work requirements, eligibility rules, provider taxes, and state financing limits). Dual-eligible beneficiaries can feel those effects, but the programs are not the same.

Both parties have adjusted Medicare payment rates for years. The Affordable Care Act included significant reductions in projected Medicare spending through lower provider updates and other mechanisms. The sustainable growth rate formula produced years of threatened physician cuts that Congress repeatedly patched. Payment policy fights are normal. Treating ordinary (or temporary) payment adjustments and the expiration of short-term subsidies as an assault on seniors is selective.

Medicare faces genuine long-term fiscal pressure from demographics and rising healthcare costs. Honest debate about solvency, incentives, fraud, and the proper scope of the program is necessary. Slogans that erase the distinction between provider payments and beneficiary benefits, ignore waived sequesters, and treat the end of temporary programs as permanent benefit cuts do not advance that debate.

The record is clear: the dramatic automatic cuts did not happen, core benefits for U.S. citizen seniors were not broadly reduced, and several of the most-cited changes involve temporary measures expiring on schedule or administrative decisions about market stabilization and program integrity. Political messaging that collapses all of that into “Republicans cut Medicare” is effective for fundraising and midterm mobilization. It is not a reliable description of what the law and the administration actually did.

Primary sources

• CBO, “CBO’s Estimates of the Statutory Pay-As-You-Go Effects of Public Law 119-21,” August 2025 (https://www.cbo.gov/system/files/2025-08/61659-SPAYGO.pdf)

• CBO, Estimated Budgetary Effects of Public Law 119-21, July 2025

• CRS Report R48569 (and related), Health Coverage Provisions in the One Big Beautiful Bill Act

• H.R. 5371 / Public Law 119-37 (November 12, 2025)

• CMS, Calendar Year 2027 Medicare Physician Fee Schedule Proposed Rule fact sheet, July 14, 2026

• CMS announcement on Part D Premium Stabilization Demonstration, July 28, 2026 (covered by ABC News, WSJ, KFF)

• Center for Medicare Advocacy, “Impact of the ‘Big Bill’ on Medicare,” July 2025